If you have chronic kidney disease, know that you belong to the category of high and very high cardiovascular risk.
According to the renal registries of Ukraine, Europe, North America, Japan and Australia, mortality from cardiovascular complications due to chronic kidney disease significantly exceeds the number of deaths from all kidney diseases, including end-stage renal failure. Moreover, cardiovascular mortality in dialysis patients is ten times higher than in the corresponding age groups in the general population, and accounts for at least 40.0% of all causes of death. Today it is clear that even mild kidney dysfunction in patients in the early stages of chronic kidney disease can increase the risk of coronary heart disease, myocardial infarction, heart failure, ectopic calcification, thrombotic complications and other cardiovascular events, significantly reducing the quality of life and prognosis.
By affecting the hemodynamic and metabolic mechanisms of increasing severity of chronic kidney disease, we simultaneously prevent cardiovascular pathology, improve the structure and function of the myocardium, central and peripheral arteries, and slow down athero- and arteriosclerotic damage.
If you are interested in nephroprotection and cardioprotection programs, contact us!
We will surely help!